Functional Analysis of Prognostic Gene Expression Network Genes in Metastatic Breast Cancer Models
Author(s) -
Thomas R. Geiger,
NgocHan Ha,
Farhoud Faraji,
Helen Michael,
Loren Rodriguez,
Renard C. Walker,
Jeffery E. Green,
R. Mark Simpson,
Kent W. Hunter
Publication year - 2014
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0111813
Subject(s) - breast cancer , metastasis , biology , gene , gene expression profiling , gene regulatory network , gene expression , cancer research , estrogen receptor , cancer , metastatic breast cancer , gene co expression network , biological network , computational biology , bioinformatics , genetics , gene ontology
Identification of conserved co-expression networks is a useful tool for clustering groups of genes enriched for common molecular or cellular functions [1] . The relative importance of genes within networks can frequently be inferred by the degree of connectivity, with those displaying high connectivity being significantly more likely to be associated with specific molecular functions [2] . Previously we utilized cross-species network analysis to identify two network modules that were significantly associated with distant metastasis free survival in breast cancer. Here, we validate one of the highly connected genes as a metastasis associated gene. Tpx2 , the most highly connected gene within a proliferation network specifically prognostic for estrogen receptor positive (ER+) breast cancers, enhances metastatic disease, but in a tumor autonomous, proliferation-independent manner. Histologic analysis suggests instead that variation of TPX2 levels within disseminated tumor cells may influence the transition between dormant to actively proliferating cells in the secondary site. These results support the co-expression network approach for identification of new metastasis-associated genes to provide new information regarding the etiology of breast cancer progression and metastatic disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom